Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like Valneva and Dynavax Collaborate to Develop COVID-19 Vaccine April 23, 2020 Dynavax Teams Up with Medigen on COVID-19 Vaccine July 22, 2020 Preceptis’ Ear Tube System Receives FDA Clearance June 22, 2020
